Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM PAR NO PAR
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
7,048,122
-
Shares change
-
-134,106
-
Total reported value, excl. options
-
$116,418,000
-
Value change
-
-$1,246,355
-
Number of buys
-
13
-
Number of sells
-
12
-
Price
-
$16.75
Institutional Holders of CYNAPSUS THERAPEUTICS INC - COM PAR NO PAR (CYNA) as of Q2 2016
35 filings reported holding CYNA - CYNAPSUS THERAPEUTICS INC - COM PAR NO PAR as of 30 Jun 2016.
CYNAPSUS THERAPEUTICS INC - COM PAR NO PAR (CYNA) had 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,048,122 shares of stock of the company.
Largest 10 holders included FRANKLIN RESOURCES INC, ORBIMED ADVISORS LLC, Aisling Capital LLC, Visium Asset Management, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Tekla Capital Management LLC, NEXTHERA CAPITAL LP, DAFNA Capital Management LLC, PURA VIDA INVESTMENTS, LLC, and First Light Asset Management, LLC.
This table shows the top 32 institutional shareholders of the security as of 30 Jun 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.